RPCONE
SUPN icon

Retirement Planning Company of New England’s Supernus Pharmaceuticals SUPN Stock Holding History

Retirement Planning Company of New England’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$635K Sell
13,655
-2,677
-16% -$129K 0.23% 119
2026
Q1 		$844K Sell
16,332
-200
-1% -$10.2K 0.34% 88
2025
Q4 		$822K Sell
16,532
-1,225
-7% -$59.6K 0.33% 87
2025
Q3 		$849K Hold
17,757
– – 0.34% 85
2025
Q2 		$560K Sell
17,757
-1,296
-7% -$41.5K 0.25% 116
2025
Q1 		$624K Sell
19,053
-2,374
-11% -$84.1K 0.31% 99
2024
Q4 		$775K Sell
21,427
-1,016
-5% -$35.8K 0.38% 76
2024
Q3 		$700K Sell
22,443
-1,127
-5% -$35.2K 0.35% 86
2024
Q2 		$630K Sell
23,570
-1,934
-8% -$56.1K 0.34% 87
2024
Q1 		$870K Sell
25,504
-25,799
-50% -$768K 0.48% 66
2023
Q4 		$1.48M Sell
51,303
-305
-0.6% -$8.09K 0.67% 38
2023
Q3 		$1.42M Buy
51,608
+23,656
+85% +$720K 0.79% 32
2023
Q2 		$840K Sell
27,952
-2,625
-9% -$91.9K 0.48% 65
2023
Q1 		$1.11M Sell
30,577
-2,262
-7% -$87K 0.67% 43
2022
Q4 		$1.17M Sell
32,839
-405
-1% -$14.1K 0.76% 36
2022
Q3 		$1.13M Sell
33,244
-4,050
-11% -$132K 0.81% 30
2022
Q2 		$1.08M Sell
37,294
-675
-2% -$19.3K 0.74% 36
2022
Q1 		$1.23M Buy
37,969
+488
+1% +$15K 0.69% 35
2021
Q4 		$1.09M Buy
+37,481
New +$1.14M 0.53% 42

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Retirement Planning Company of New England's SUPN Position: Q2 2026 in Review

Retirement Planning Company of New England reduced its Supernus Pharmaceuticals (SUPN) stake by 16% in Q2 2026, selling an estimated $129K and leaving 13,655 shares worth $635K. The position accounts for 0.23% of the portfolio, ranked #119.

Retirement Planning Company of New England first reported a position in SUPN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.48M in Q4 2023. 180 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Retirement Planning Company of New England held 13,655 shares of Supernus Pharmaceuticals worth $635K as of Q2 2026.
  • Retirement Planning Company of New England sold 2,677 Supernus Pharmaceuticals shares in Q2 2026, an estimated $129K.
  • Supernus Pharmaceuticals made up 0.23% of Retirement Planning Company of New England's portfolio in Q2 2026, its #119 holding.
  • Retirement Planning Company of New England first reported a position in Supernus Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Retirement Planning Company of New England's Supernus Pharmaceuticals position peaked at $1.48M in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Retirement Planning Company of New England's 13F filing for Q2 2026, filed 30 Jul 2026.